Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The greatest explosion of managers

It is hard to find points of light at a time when American unemployment claims hit a record 6.6m last week, on top of 3.3m the week before, due to the economic disruption caused by coronavirus.

CVC in the Time of Coronavirus:…

Total Carbon Neutrality Ventures’ international outlook has eased the switch to remote working somewhat, and opportunities are available for careful investors.


GCV Symposium 2020
3rd June 2020
Tech startups eligible for $350bn US lending scheme
Startups with fewer than 500 employees will be able to apply for loans of up to $10m from the US government's $350bn Paycheck Protection Program.
AM-Pharma amplifies latest round to $182m
Cowen and European Investment Bank added $52m to a $130m first tranche closed by the AbbVie and Pfizer-backed kidney injury drug developer in July.
6 Dimensions supports $125m round for iTeos
The WuXi-backed investment firm returned for a series B2 round that will support phase 1/2 trials for iTeos Therapeutics' oncology therapies.
Pandion packs in $80m
Autoimmune disease drug developer Pandion Therapeutics closed a series B round co-led by Access Biotechnology and backed by Roche Venture Fund and SR One.
Collibra collects $112m
CapitalG returned for a late-stage round that pushed Collibra’s total funding beyond $345m and boosted its valuation to $2.3bn.
Aspen Neuroscience ascends with $70m
The Parkinson's disease therapy developer closed the series A funding less than four months after a Eurofarma-backed seed round.
test reg